Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137253 · ClinicalTrials.gov registry record · Phase 1
Autonomic Nervous System and Nitric Oxide Interactions
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01137253 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 21 participants.
The verdict
NCT01137253, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators are interested in the role of the autonomic nervous system in the regulation of endothelial function among obese hypertensive subjects. In particular, the investigators will study how endothelial function (response to intra-arterial acetylcholine) changes during autonomic withdrawal.
Interventions
- DRUG Placebo
- DRUG Trimethaphan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137253
The ClinicalTrials.gov registry entry for NCT01137253 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01137253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01137253 about?
NCT01137253 is a clinical study titled "Autonomic Nervous System and Nitric Oxide Interactions". The investigators are interested in the role of the autonomic nervous system in the regulation of endothelial function among obese hypertensive subjects. In particular, the investigators will study how endothelial function (response to intra-arterial acetylcholine) changes during autonomic withdrawa...
What is the current status of trial NCT01137253?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2010-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01137253?
The interventions under investigation include: Placebo (DRUG), Trimethaphan (DRUG).
Who is sponsoring clinical trial NCT01137253?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.